scholarly journals Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake

2018 ◽  
Vol Volume 11 ◽  
pp. 8301-8307 ◽  
Author(s):  
Hiroki Osumi ◽  
Daisuke Takahari ◽  
Keisho Chin ◽  
Mariko Ogura ◽  
Takashi Ichimura ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Oral Intake ◽  
Line Treatment ◽  
First Line ◽  
Massive Ascites ◽  
Modified Folfox6 ◽  
Inadequate Oral Intake ◽  
First Line Treatment

scholarly journals Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)

2011 ◽  
Vol 14 (1) ◽  
pp. 72-80 ◽  
Author(s):  
Hiroyuki Narahara ◽  
Hiroyasu Iishi ◽  
Hiroshi Imamura ◽  
Akira Tsuburaya ◽  
Keisho Chin ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Iii ◽  
Line Treatment ◽  
Efficacy And Safety ◽  
First Line ◽  
Cancer Study ◽  
Gastric Cancer Study ◽  
Phase Iii Study ◽  
First Line Treatment

Docetexal plus S-1 Versus Oxaliplatin plus S-1 for First-Line Treatment of Patients with Advanced Gastric Cancer: A Retrospective Study

2014 ◽  
Vol 37 (1-2) ◽  
pp. 24-28 ◽  
Author(s):  
Mei Wang ◽  
Meihong Wu ◽  
Wei Wang ◽  
Qingshui Wang ◽  
Yajie Wang
Keyword(s):  
Gastric Cancer ◽  
Retrospective Study ◽  
Advanced Gastric Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study

2015 ◽  
Vol 76 (6) ◽  
pp. 1267-1272 ◽  
Author(s):  
Young Saing Kim ◽  
Sun Jin Sym ◽  
Min Young Baek ◽  
Inkeun Park ◽  
Junshik Hong ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Pilot Study ◽  
Advanced Gastric Cancer ◽  
Low Dose ◽  
Line Treatment ◽  
First Line ◽  
Her2 Positive ◽  
First Line Treatment

scholarly journals First‐line mFOLFOX6 for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake

2018 ◽  
Vol 29 ◽  
pp. v23
Author(s):  
H. Osumi ◽  
D. Takahari ◽  
K. Chin ◽  
M. Ogura ◽  
T. Ichimura ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Oral Intake ◽  
First Line ◽  
Massive Ascites ◽  
Inadequate Oral Intake

Paclitaxel, 5-fluorouracil, and leucovorin combination chemotherapy as first-line treatment in patients with advanced gastric cancer

2019 ◽  
Vol 30 (3) ◽  
pp. 302-307 ◽  
Author(s):  
Wan-Cai Que ◽  
Yan-Fang Huang ◽  
Xiao-Yan Lin ◽  
Yan-Qin Lan ◽  
Xin-Yan Gao ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Combination Chemotherapy ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

6592 POSTER 5-Fluorouracil/Leucovorin, Oxaliplatin and Irinotecan (FOLFOXIRI) as First-Line Treatment of Advanced Gastric Cancer

2011 ◽  
Vol 47 ◽  
pp. S469
Author(s):  
C. Grande ◽  
M. Martinez ◽  
M.J. Villanueva ◽  
G. Huidobro ◽  
J. Casal
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Docetaxel plus Oxaliplatin in Combination with Capecitabine as First-Line Treatment for Advanced Gastric Cancer

Oncology ◽  
2011 ◽  
Vol 80 (5-6) ◽  
pp. 359-365 ◽  
Author(s):  
K. Amarantidis ◽  
N. Xenidis ◽  
L. Chelis ◽  
E. Chamalidou ◽  
P. Dimopoulos ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial

2019 ◽  
Vol 84 (6) ◽  
pp. 1365-1365
Author(s):  
Fernando Rivera ◽  
C. Romero ◽  
P. Jimenez-Fonseca ◽  
M. Izquierdo-Manuel ◽  
A. Salud ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Line Treatment ◽  
First Line ◽  
Her2 Positive ◽  
First Line Treatment

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine.

scholarly journals P-280 The comparison of mFOLFOX-6, mDCF, mFOLFIRINOX in the first-line treatment of advanced gastric cancer

2020 ◽  
Vol 31 ◽  
pp. S181
Author(s):  
E. Ignatova ◽  
M. Fedyanin ◽  
I. Pokataev ◽  
A. Tryakin ◽  
A. Popova ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document